Scientists test brain drug safety in people with kidney issues
NCT ID NCT05718843
Summary
This study tested how kidney function affects the way a new brain medicine, called iclepertin, is processed by the body. It involved 36 adults, some with healthy kidneys and others with mild to severe kidney problems. Each participant took a single dose of the medicine, and researchers measured its levels in the blood over several weeks to understand the differences.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, 24105, Germany
Conditions
Explore the condition pages connected to this study.